News

Certara® and Paidion Research, announced a new partnership to address the challenges inherent in pediatric drug development.

ACRP believes the arbitrary two-years experience generally required throughout the industry is contributing to a shortage of CRAs and negatively impacting efficiencies and quality in clinical research.

The analysis compared various manifestations between genotypes and to determine if correlations exist between TSC symptoms and the TSC gene mutation.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that its Clinical Cloud platform has been adopted by Walvax Biotechnology.

We all need help sometimes. For pharmaceutical companies, this often comes in the form of a reliable and competent contract research organization.

Almac announced the expansion of its shipping service for clinical trials to EU countries.

The US ophthalmology-focused CRO will use the solution to provide real-time key operational parameters.

The world of RBM is continually changing as biopharmaceutical enterprises are dabbling into different approaches and methods. There are several outsourced models that exist, when approaching RBM, such as integrating cloud-based solutions to provide centralized monitoring teams with analytics, or fully outsourcing RBM functions and technologies to CROs.  However, some companies, such as Novartis, appear to be in-sourcing their RBM technologies and functions. 

BioClinica’s eHealth App xChange provides access to an ecosystem of integrated mobile and cloud applications.

A staggering number of clinical trials fail to meet recruitment goals, which leads to delays, early trial termination, or inability to draw conclusions at trial completion due to loss of statistical power.

PPD and CISYS LifeSciences announced PPD’s implementation of Sequence WebEAS, a new Web-based event adjudication system, through a collaboration between the two companies.

Kayentis, a French software provider specialized in solutions for clinical trials, has chosen SFR Business Team for its M2M roaming in close to 250 countries.

The U.K. National Health Service (NHS) has granted approval for what is thought to be the first use of electronic informed consent in England.

As the push to contain clinical trial costs and make informed business decisions continues, more pharma and CROs are looking at internal and external benchmarking and metrics to evaluate their performance-both successes and challenges. This e-Book includes articles that show how analytics uncover problem areas in clinical operations, as well as metrics and databases that are used to pinpoint internal or external performance issues.

An article recently appeared in Applied Clinical Trials, which indicated that oncology trials are taking longer to complete, and the article suggested that the duration of oncology clinical trials in certain phases increased by one year to one and a half years.1 Moreover, the article delineates that ameliorations in trial duration were most likely a result of increasing protocol complexi

Across the pharmaceutical industry, advances in digital technology play a key role in driving the efficiency of the drug development process, particularly for clinical trials.

 The Top 5 Risk-Based Monitoring Articles